Measurement of rectum dose by in vivo alanine/ESR dosimetry in gynecological 192Ir HDR brachytherapy

Bravo-Miranda, C. A.; Rech, Amanda Burg; Oliveira, Harley Francisco de; Bertucci, Edenyse C.; Córdova–Fraga, Teodoro; Baffa, Oswaldo

doi:10.1016/j.radmeas.2015.03.006

Cited by 4 publications

(1 citation statement)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Until now, many clinical trials have been performed using passive type dosimeters. Reports concerning thermo-luminescent dosimeters, 26 alanine/electron spin resonance (ESR) dosimeters, 27 and optically stimulated luminescence (OSL) dosimeters 25,[28][29][30][31][32][33][34][35] have been published. In this study, we focused our attention on the OSL dosimeter, which is composed of Al 2 O 3 :C, because this dosimeter has good characteristics for dosimetry in the medical field.…”

Section: Introductionmentioning

confidence: 99%

A disposable OSL dosimeter for in vivo measurement of rectum dose during brachytherapy

et al. 2021

View full text Add to dashboard Cite

Purpose We aimed to develop a disposable rectum dosimeter and to demonstrate its ability to measure exposure dose to the rectum during brachytherapy for cervical cancer treatment using high‐dose rate 192Ir. Our rectum dosimeter measures the dose with an optically stimulated luminescence (OSL) sheet which was furled to a catheter. The catheter we used is 6 mm in diameter; therefore, it is much less invasive than other rectum dosimeters. The rectum dosimeter developed in this study has the characteristics of being inexpensive and disposable. It is also an easy‐to‐use detector that can be individually sterilized, making it suitable for clinical use. Methods To obtain a dose calibration curve, phantom experiments were performed. Irradiation was performed using a cubical acrylic phantom, and the response of the OSL dosimeter was calibrated with the calculation value predicted by the treatment planning system (TPS). Additionally, the dependence of catheter angle on the dosimeter position and repeatability were evaluated. We also measured the absorbed dose to the rectum of patients who were undergoing brachytherapy for cervical cancer (n = 64). The doses measured with our dosimeters were compared with the doses calculated by the TPS. In order to examine the causes of large differences between measured and planned doses, we classified the data into common and specific cases when performing this clinical study. For specific cases, the following three categories were considered: (a) patient movement, (b) gas in the vagina and/or rectum, and (c) artifacts in the X‐ray image caused by applicators. Results A dose calibration curve was obtained in the range of 0.1 Gy–10.0 Gy. From the evaluation of the dependence of catheter angle on the dosimeter position and repeatability, we determined that our dosimeter can measure rectum dose with an accuracy of 3.1% (k = 1). In this clinical study, we succeeded in measuring actual doses using our rectum dosimeter. We found that the deviation of the measured dose from the planned dose was derived to be 12.7% (k = 1); this result shows that the clinical study included large elements of uncertainty. The discrepancies were found to be due to patient motion during treatment, applicator movement after planning images were taken, and artifacts in the planning images. Conclusions We present the idea that a minimally invasive rectum dosimeter can be fabricated using an OSL sheet. Our clinical study demonstrates that a rectum dosimeter made from an OSL sheet has sufficient ability to evaluate rectum dose. Using this dosimeter, valuable information concerning organs at risk can be obtained during brachytherapy.

show abstract